SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 29.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 202.26m
  • Volume: 122,323
  • Market Cap: £18.71m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 29.00
52 Week Low 7.25
Volume 122,323
Shares Issued 202.26m
Market Cap £18.71m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.96% below the market average70.96% below the market average70.96% below the market average70.96% below the market average70.96% below the market average
84.31% below the sector average84.31% below the sector average84.31% below the sector average84.31% below the sector average84.31% below the sector average
Price Trend
82.36% below the market average82.36% below the market average82.36% below the market average82.36% below the market average82.36% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
19.03% above the market average19.03% above the market average19.03% above the market average19.03% above the market average19.03% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

SBTX Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:27 17,500 @ 9.36p
15:30 20,000 @ 9.13p
15:30 20,000 @ 9.00p
13:58 5,613 @ 9.37p
13:02 10,630 @ 9.36p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page